New drug duo tested in fight against spreading skin cancer
Disease control
Terminated
This study tested a combination of two drugs, cabozantinib and pembrolizumab, as a first treatment for adults with advanced melanoma that had spread and could not be surgically removed. The main goals were to find a safe dose for the combination and to see how well it worked at s…
Phase: PHASE1, PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC